Bank of America
NWBO

Bank of America’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Bank of America’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-14,465
Closed -$8K – 7745
2016
Q3 		$8K Sell
14,465
-13,389
-48% -$6.12K ﹤0.01% 6479
2016
Q2 		$16K Buy
27,854
+17,204
+162% +$18.4K ﹤0.01% 6349
2016
Q1 		$16K Sell
10,650
-15,533
-59% -$30.6K ﹤0.01% 6242
2015
Q4 		$84K Sell
26,183
-832
-3% -$4K ﹤0.01% 5810
2015
Q3 		$169K Sell
27,015
-6,175
-19% -$57.7K ﹤0.01% 5422
2015
Q2 		$329K Buy
33,190
+6,548
+25% +$57.3K ﹤0.01% 4987
2015
Q1 		$197K Sell
26,642
-36,576
-58% -$246K ﹤0.01% 4936
2014
Q4 		$339K Sell
63,218
-450
-0.7% -$2.3K ﹤0.01% 4942
2014
Q3 		$320K Buy
63,668
+7,068
+12% +$43.4K ﹤0.01% 4979
2014
Q2 		$380K Buy
56,600
+40,600
+254% +$258K ﹤0.01% 4894
2014
Q1 		$116K Sell
16,000
-18,036
-53% -$107K ﹤0.01% 5877
2013
Q4 		$128K Buy
34,036
+29,036
+581% +$112K ﹤0.01% 5950
2013
Q3 		$17K Buy
5,000
+2,175
+77% +$7.57K ﹤0.01% 6973
2013
Q2 		$9K Buy
+2,825
New +$10.2K ﹤0.01% 7216

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Bank of America's NWBO Position: Q4 2016 in Review

Bank of America sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 14,465 shares — an estimated $8K sold.

Bank of America first reported a position in NWBO in Q2 2013 and held it in 14 quarters. The position peaked at $380K in Q2 2014. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Bank of America reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Bank of America sold 14,465 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $8K.
  • Bank of America first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2013 and held it in 14 quarters.
  • Bank of America's Northwest Biotherapeutics, Inc. Common stock position peaked at $380K in Q2 2014.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.